UPDATE 1-Drugs standards group nixes plan to kick pharma's crab blood habit
May 30, 2020 at 18:34 PM EDT
Horseshoe crabs' icy-blue blood will remain the drug industry's standard for safety tests after a powerful U.S. group ditched a plan to give equal status to a synthetic substitute pushed by Swiss biotech Lonza and animal welfare groups.
